5:33 PM
 | 
Jun 12, 2012
 |  BC Extra  |  Politics & Policy

Five companies join NIH repurposing program

Five pharmas joined NIH's compound repurposing initiative. Abbott Laboratories (NYSE:ABT); Bristol-Myers Squibb Co. (NYSE:BMY); GlaxoSmithKline plc (LSE:GSK; NYSE:GSK); Johnson & Johnson (NYSE:JNJ); and Sanofi (Euronext:SAN; NYSE:SNY) joined...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >